Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Operating Expenses (2016 - 2026)

Organogenesis Holdings has reported Other Operating Expenses over the past 6 years, most recently at $321.4 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 209.88% year-over-year to $321.4 million; the TTM value through Dec 2025 reached $300.6 million, up 64.72%, while the annual FY2025 figure was $148.7 million, 7.33% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $321.4 million at Organogenesis Holdings, up from -$56.7 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $321.4 million in Q4 2025 and troughed at -$207.7 million in Q4 2023.
  • A 3-year average of $34.4 million and a median of $28.1 million in 2024 define the central range for Other Operating Expenses.
  • On a YoY basis, Other Operating Expenses climbed as much as 209.88% in 2025 and fell as far as 311.65% in 2025.
  • Year by year, Other Operating Expenses stood at -$207.7 million in 2023, then soared by 149.95% to $103.7 million in 2024, then skyrocketed by 209.88% to $321.4 million in 2025.
  • Business Quant data shows Other Operating Expenses for ORGO at $321.4 million in Q4 2025, -$56.7 million in Q3 2025, and $29.4 million in Q2 2025.